CHO Pharma Balance Sheet Health
Financial Health criteria checks 6/6
CHO Pharma has a total shareholder equity of NT$2.9B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$3.0B and NT$134.8M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$2.49b |
| Equity | NT$2.88b |
| Total liabilities | NT$134.83m |
| Total assets | NT$3.01b |
Financial Position Analysis
Short Term Liabilities: 6586's short term assets (NT$2.5B) exceed its short term liabilities (NT$108.3M).
Long Term Liabilities: 6586's short term assets (NT$2.5B) exceed its long term liabilities (NT$26.6M).
Debt to Equity History and Analysis
Debt Level: 6586 is debt free.
Reducing Debt: 6586 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6586 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6586 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 0.3% each year